---
$id: https://graph.org.ai/products/commodity/51131508
$type: Product
source: UNSPSC
code: "51131508"
title: "Epoetin alfa"
class: "51131500"
classTitle: "Antianemic drugs"
family: "51130000"
familyTitle: "Hematolic drugs"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Epoetin alfa

**UNSPSC Code**: 51131508
**Class**: [Antianemic drugs](Antianemic drugs.mdx)
**Family**: [Hematolic drugs](../Hematolic drugs.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes a chemotherapy regimen used to treat non-hodgkins lymphoma with the molecular formula C809H1301N229O240S5, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 64FS3BFH5W, more generally known as epoetin alfa. European Medicines Agency schedules epoetin alfa in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB06575MIG. The term ERYTHROPOIETIN is an International Non-Proprietary Name or INN. Epoetin alfa bears US NLM identifiers UMLS ID C0357126 and NCI Concept Code C2695.

